US2003068347A1PendingUtilityA1
Use of microbially encapsulated meterials in cosmetic end formulations
Priority: Jan 10, 2000Filed: Jan 4, 2001Published: Apr 10, 2003
Est. expiryJan 10, 2020(expired)· nominal 20-yr term from priority
A61Q 13/00A61Q 1/02A61K 8/11A61K 8/347A61K 8/9733A61K 8/9794A61Q 17/00A61Q 11/00A61K 8/69A61K 8/671A61K 8/678A61Q 3/00A61K 8/676A61Q 15/00A61K 8/922A61Q 19/04A61K 8/9789A61K 8/99A61Q 19/10A61K 8/9706A61Q 9/02A61K 2800/412A61Q 17/02A61Q 19/002A61Q 19/02A61Q 5/02A61Q 5/00A61K 8/046A61Q 19/004A61Q 17/04A61Q 19/00A61K 8/9728
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The use of microbially encapsulated materials (filled biocapsules), in particular yeast, in cosmetic end formulations is described.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . The use of microbially encapsulated materials (filled biocapsules) in cosmetic end formulations, wherein the biocapsules comprise one or more liquid or microbially encapsulatable cosmetic ingredients.
2 . The use according to claim 1 , wherein the biocapsules consist of yeast.
3 . The use according to claim 1 or 2 , wherein the microbially encapsulatable cosmetic ingredients are chosen from fragrances and cosmetic oils which can be applied dermally, from skincare and skin-cleansing substances, from active ingredients having a deodorizing and antiperspirant action, UV filters, active ingredients against insects, active ingredients for protecting against chemical and mechanical effects, humectant substances, active ingredients having a keratoplastic or keratolytic effect, antimicrobial agents, oily or oil-soluble vitamins or vitamin derivatives which can be applied dermally, vitamin-based placenta extracts, skin repair complexes, plants and plant extracts, animal extracts, dyes, antioxidants, skin-tanning and skin-whitening substances, and other cosmetic active ingredients.
4 . The use according to claim 3 , wherein the microbially encapsulatable cosmetic ingredients are chosen from triclosan, diclosan or 4-(2-tert-butyl-5-methylphenoxy)phenol.
5 . The use according to any one of claims 1 to 4 , wherein the cosmetic ingredients are present in the microbially encapsulated material as individual substances or as a mixture of two or more substances.
6 . The use according to any one of claims 1 to 5 , wherein the microbially encapsulatable cosmetic ingredients are present in the encapsulated material in a concentration of from 1 to 80% by weight, based on the total weight of the filled biocapsules.
7 . The use according to any one of claims 1 to 6 , wherein the microbially encapsulated ingredients are each present in the cosmetic end formulation in a concentration of from 0.01 to 20% by weight, based on the cosmetic end formulation.
8 . A cosmetic end formulation in the form of a gel, comprising the microbially encapsulated material as defined in claim 1 .
9 . A cosmetic end formulation in the form of a cream, a lotion or a milk, comprising the microbially encapsulated material as defined in claim 1 .
10 . A cosmetic end formulation in the form of a stick, comprising the microbially encapsulated material as defined in claim 1 .
11 . A cosmetic end formulation in the form of a spray or aerosol, comprising the microbially encapsulated material as defined in claim 1 .
12 . A cosmetic end formulation in the form of a foam, comprising the microbially encapsulated material as defined in claim 1 .
13 . A cosmetic end formulation in the form of a paste, comprising the microbially encapsulated material as defined in claim 1 .
14 . A cosmetic end formulation in the form of a powder, a varnish, a tablet or make-up, comprising the microbially encapsulated material as defined in claim 1 .
15 . The use of the cosmetic end formulation according to any one of claims 8 to 14 for the care and protection of the skin, mucous membrane, oral cavities, hair or nails.
16 . The use of the cosmetic end formulation according to any one of claims 8 to 14 as a sunscreen or as an “aftersun” preparation.
17 . The use of the cosmetic end formulation according to any one of claims 8 to 14 for shaving or as an “aftershave” preparation.
18 . The use of the cosmetic end formulation according to any one of claims 8 to 14 as perfume, eau de toilette or deodorant.Join the waitlist — get patent alerts
Track US2003068347A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.